- Home
- STEM vs ZURA Comparison
STEM vs ZURA Comparison
Compare STEM & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEM
- ZURA
- Stock Information
- Founded
- STEM 2009
- ZURA 2022
- Country
- STEM United States
- ZURA United States
- Employees
- STEM N/A
- ZURA N/A
- Industry
- STEM Computer Software: Prepackaged Software
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STEM Technology
- ZURA Health Care
- Exchange
- STEM Nasdaq
- ZURA Nasdaq
- Market Cap
- STEM 75.7M
- ZURA 69.9M
- IPO Year
- STEM N/A
- ZURA N/A
- Fundamental
- Price
- STEM $14.99
- ZURA $1.64
- Analyst Decision
- STEM Hold
- ZURA Buy
- Analyst Count
- STEM 9
- ZURA 7
- Target Price
- STEM $23.38
- ZURA $14.33
- AVG Volume (30 Days)
- STEM 861.9K
- ZURA 1.3M
- Earning Date
- STEM 08-07-2025
- ZURA 08-08-2025
- Dividend Yield
- STEM N/A
- ZURA N/A
- EPS Growth
- STEM N/A
- ZURA N/A
- EPS
- STEM N/A
- ZURA N/A
- Revenue
- STEM $151,627,000.00
- ZURA N/A
- Revenue This Year
- STEM $5.22
- ZURA N/A
- Revenue Next Year
- STEM $18.56
- ZURA N/A
- P/E Ratio
- STEM N/A
- ZURA N/A
- Revenue Growth
- STEM N/A
- ZURA N/A
- 52 Week Low
- STEM $5.81
- ZURA $0.97
- 52 Week High
- STEM $33.60
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- STEM 68.28
- ZURA 61.26
- Support Level
- STEM $8.29
- ZURA $1.60
- Resistance Level
- STEM $18.59
- ZURA $1.79
- Average True Range (ATR)
- STEM 1.71
- ZURA 0.18
- MACD
- STEM 0.74
- ZURA 0.03
- Stochastic Oscillator
- STEM 65.07
- ZURA 50.91
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.